Board Meeting25 Jul 2026, 02:01 pm
GPT Healthcare Board Meeting on Aug 3 to Approve Q1 FY27 Results
AI Summary
GPT Healthcare Ltd has announced that its Board of Directors will convene on August 3, 2026. The primary agenda item is to consider and approve the Unaudited Financial Results for the first quarter ended June 30, 2026, along with the Statutory Auditor's Limited Review Report. The trading window for company securities will remain closed until August 5, 2026, to prevent insider trading, as per the company's code of conduct. This information is also available on the company's website.
Key Highlights
- Board meeting scheduled for August 3, 2026.
- To approve Q1 FY27 Unaudited Financial Results.
- Limited Review Report to be considered.
- Trading window closure extended until August 5, 2026.
- Insider trading prevention measures in place.
Price Impact
More from GPTHEALTH